Loading…
Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: The experience of the Department of Calvados (France)
Summary Colorectal cancers emerging after a negative Haemoccult II ® are described in the context of a first round of mass screening in the Department of Calvados (France), from April 1991 to the end of December 1994. People with a cancer occurring after a negative test until 31 December 1995 were i...
Saved in:
Published in: | British Journal of Cancer 1999-09, Vol.81 (2), p.305-309 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c477t-382242d9f006e917999f53ebe55ebf9278c30261b9567f524ab8e1b7d3657fe23 |
---|---|
cites | cdi_FETCH-LOGICAL-c477t-382242d9f006e917999f53ebe55ebf9278c30261b9567f524ab8e1b7d3657fe23 |
container_end_page | 309 |
container_issue | 2 |
container_start_page | 305 |
container_title | British Journal of Cancer |
container_volume | 81 |
creator | Bouvier, V Launoy, G Herbert, C Lefevre, H Maurel, J Gignoux, M |
description | Summary
Colorectal cancers emerging after a negative Haemoccult II
®
are described in the context of a first round of mass screening in the Department of Calvados (France), from April 1991 to the end of December 1994. People with a cancer occurring after a negative test until 31 December 1995 were identified by a local cancer registry. Incidence was calculated and the programme sensitivity was estimated. The incidence of cancer emerging after a negative test was 57.7 per 100 000, i.e. half of the calculated incidence in the reference group (141.6 per 100 000). These cancers did not differ from those of either the non-responder or reference groups, in particular for the stage of extension. The programme sensitivity was globally higher than that estimated in European trials: 77.2, 66.3 and 55.9%, 1, 2 and 3 years after the test respectively. Programme sensitivity was higher for distal colon cancer 1 year after the test, which is probably due to the relatively slow growth of this subsite. |
doi_str_mv | 10.1038/sj.bjc.6990692 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2362867</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70049004</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-382242d9f006e917999f53ebe55ebf9278c30261b9567f524ab8e1b7d3657fe23</originalsourceid><addsrcrecordid>eNp1ksFu1DAQhiMEokvhyg3kA6rgsFvH2dhxD0jVQulKlbiUs-U449RRYgfbWdEn4jVxlNVSDhxsS_6_-Wc84yx7m-NNjovqMnSbulMbyjmmnDzLVvmW0XVZVPnzbIUxZmvMCT7LXoXQYZxEVr7MznK85bQo2Sr7vXO986Ci7JGSVoFHUsd5RxZaGc0B0K2EwSk19RHt9yhCiEjaBo3etV4OA6AANpiEmvh4itbGJ867KZFOo6A8gDW2vUL3D4Dg1wjeQMo3izHdfIFR-jiAjfPNTvYH2biAPt74uapPr7MXWvYB3hzP8-zHzdf73e367vu3_e76bq3S0-K6qAjZkoZrjCnwnHHOdVlADWUJteaEVarAhOY1LynTJdnKuoK8Zk1BS6aBFOfZ58V3nOoBGpXq8bIXozeD9I_CSSP-Vax5EK07CFJQUlGWDC6OBt79nFKvxGCCgr6XFtwUBMOp92klcLOAyrsQPOhTkhyLebYidCLNVhxnmwLePy3tCb4MMwEfjoAMSvZ67pwJf7n0EQiZfS4XLCTFtuBF5yZvU1f_n_ndEmFlnDycHCld9D9zdcot</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70049004</pqid></control><display><type>article</type><title>Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: The experience of the Department of Calvados (France)</title><source>Wiley-Blackwell Read & Publish Collection</source><source>PubMed Central</source><creator>Bouvier, V ; Launoy, G ; Herbert, C ; Lefevre, H ; Maurel, J ; Gignoux, M</creator><creatorcontrib>Bouvier, V ; Launoy, G ; Herbert, C ; Lefevre, H ; Maurel, J ; Gignoux, M</creatorcontrib><description>Summary
Colorectal cancers emerging after a negative Haemoccult II
®
are described in the context of a first round of mass screening in the Department of Calvados (France), from April 1991 to the end of December 1994. People with a cancer occurring after a negative test until 31 December 1995 were identified by a local cancer registry. Incidence was calculated and the programme sensitivity was estimated. The incidence of cancer emerging after a negative test was 57.7 per 100 000, i.e. half of the calculated incidence in the reference group (141.6 per 100 000). These cancers did not differ from those of either the non-responder or reference groups, in particular for the stage of extension. The programme sensitivity was globally higher than that estimated in European trials: 77.2, 66.3 and 55.9%, 1, 2 and 3 years after the test respectively. Programme sensitivity was higher for distal colon cancer 1 year after the test, which is probably due to the relatively slow growth of this subsite.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1476-5381</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/sj.bjc.6990692</identifier><identifier>PMID: 10496357</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Aged ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Colorectal Neoplasms - prevention & control ; Drug Resistance ; Epidemiology ; Female ; France ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Male ; Mass Screening ; Medical sciences ; Middle Aged ; Molecular Medicine ; Occult Blood ; Oncology ; Regular ; regular-article ; Sensitivity and Specificity ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Tumors</subject><ispartof>British Journal of Cancer, 1999-09, Vol.81 (2), p.305-309</ispartof><rights>The Author(s) 1999</rights><rights>1999 INIST-CNRS</rights><rights>Copyright © 1999 Cancer Research Campaign 1999 Cancer Research Campaign</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-382242d9f006e917999f53ebe55ebf9278c30261b9567f524ab8e1b7d3657fe23</citedby><cites>FETCH-LOGICAL-c477t-382242d9f006e917999f53ebe55ebf9278c30261b9567f524ab8e1b7d3657fe23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362867/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362867/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1920222$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10496357$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bouvier, V</creatorcontrib><creatorcontrib>Launoy, G</creatorcontrib><creatorcontrib>Herbert, C</creatorcontrib><creatorcontrib>Lefevre, H</creatorcontrib><creatorcontrib>Maurel, J</creatorcontrib><creatorcontrib>Gignoux, M</creatorcontrib><title>Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: The experience of the Department of Calvados (France)</title><title>British Journal of Cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>Summary
Colorectal cancers emerging after a negative Haemoccult II
®
are described in the context of a first round of mass screening in the Department of Calvados (France), from April 1991 to the end of December 1994. People with a cancer occurring after a negative test until 31 December 1995 were identified by a local cancer registry. Incidence was calculated and the programme sensitivity was estimated. The incidence of cancer emerging after a negative test was 57.7 per 100 000, i.e. half of the calculated incidence in the reference group (141.6 per 100 000). These cancers did not differ from those of either the non-responder or reference groups, in particular for the stage of extension. The programme sensitivity was globally higher than that estimated in European trials: 77.2, 66.3 and 55.9%, 1, 2 and 3 years after the test respectively. Programme sensitivity was higher for distal colon cancer 1 year after the test, which is probably due to the relatively slow growth of this subsite.</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Colorectal Neoplasms - prevention & control</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>Female</subject><subject>France</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Male</subject><subject>Mass Screening</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Molecular Medicine</subject><subject>Occult Blood</subject><subject>Oncology</subject><subject>Regular</subject><subject>regular-article</subject><subject>Sensitivity and Specificity</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1476-5381</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNp1ksFu1DAQhiMEokvhyg3kA6rgsFvH2dhxD0jVQulKlbiUs-U449RRYgfbWdEn4jVxlNVSDhxsS_6_-Wc84yx7m-NNjovqMnSbulMbyjmmnDzLVvmW0XVZVPnzbIUxZmvMCT7LXoXQYZxEVr7MznK85bQo2Sr7vXO986Ci7JGSVoFHUsd5RxZaGc0B0K2EwSk19RHt9yhCiEjaBo3etV4OA6AANpiEmvh4itbGJ867KZFOo6A8gDW2vUL3D4Dg1wjeQMo3izHdfIFR-jiAjfPNTvYH2biAPt74uapPr7MXWvYB3hzP8-zHzdf73e367vu3_e76bq3S0-K6qAjZkoZrjCnwnHHOdVlADWUJteaEVarAhOY1LynTJdnKuoK8Zk1BS6aBFOfZ58V3nOoBGpXq8bIXozeD9I_CSSP-Vax5EK07CFJQUlGWDC6OBt79nFKvxGCCgr6XFtwUBMOp92klcLOAyrsQPOhTkhyLebYidCLNVhxnmwLePy3tCb4MMwEfjoAMSvZ67pwJf7n0EQiZfS4XLCTFtuBF5yZvU1f_n_ndEmFlnDycHCld9D9zdcot</recordid><startdate>19990901</startdate><enddate>19990901</enddate><creator>Bouvier, V</creator><creator>Launoy, G</creator><creator>Herbert, C</creator><creator>Lefevre, H</creator><creator>Maurel, J</creator><creator>Gignoux, M</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19990901</creationdate><title>Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: The experience of the Department of Calvados (France)</title><author>Bouvier, V ; Launoy, G ; Herbert, C ; Lefevre, H ; Maurel, J ; Gignoux, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-382242d9f006e917999f53ebe55ebf9278c30261b9567f524ab8e1b7d3657fe23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Colorectal Neoplasms - prevention & control</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>Female</topic><topic>France</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Male</topic><topic>Mass Screening</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Molecular Medicine</topic><topic>Occult Blood</topic><topic>Oncology</topic><topic>Regular</topic><topic>regular-article</topic><topic>Sensitivity and Specificity</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bouvier, V</creatorcontrib><creatorcontrib>Launoy, G</creatorcontrib><creatorcontrib>Herbert, C</creatorcontrib><creatorcontrib>Lefevre, H</creatorcontrib><creatorcontrib>Maurel, J</creatorcontrib><creatorcontrib>Gignoux, M</creatorcontrib><collection>SpringerOpen</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British Journal of Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bouvier, V</au><au>Launoy, G</au><au>Herbert, C</au><au>Lefevre, H</au><au>Maurel, J</au><au>Gignoux, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: The experience of the Department of Calvados (France)</atitle><jtitle>British Journal of Cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>1999-09-01</date><risdate>1999</risdate><volume>81</volume><issue>2</issue><spage>305</spage><epage>309</epage><pages>305-309</pages><issn>0007-0920</issn><eissn>1476-5381</eissn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>Summary
Colorectal cancers emerging after a negative Haemoccult II
®
are described in the context of a first round of mass screening in the Department of Calvados (France), from April 1991 to the end of December 1994. People with a cancer occurring after a negative test until 31 December 1995 were identified by a local cancer registry. Incidence was calculated and the programme sensitivity was estimated. The incidence of cancer emerging after a negative test was 57.7 per 100 000, i.e. half of the calculated incidence in the reference group (141.6 per 100 000). These cancers did not differ from those of either the non-responder or reference groups, in particular for the stage of extension. The programme sensitivity was globally higher than that estimated in European trials: 77.2, 66.3 and 55.9%, 1, 2 and 3 years after the test respectively. Programme sensitivity was higher for distal colon cancer 1 year after the test, which is probably due to the relatively slow growth of this subsite.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>10496357</pmid><doi>10.1038/sj.bjc.6990692</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-0920 |
ispartof | British Journal of Cancer, 1999-09, Vol.81 (2), p.305-309 |
issn | 0007-0920 1476-5381 1532-1827 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2362867 |
source | Wiley-Blackwell Read & Publish Collection; PubMed Central |
subjects | Aged Biological and medical sciences Biomedical and Life Sciences Biomedicine Cancer Research Colorectal Neoplasms - prevention & control Drug Resistance Epidemiology Female France Gastroenterology. Liver. Pancreas. Abdomen Humans Male Mass Screening Medical sciences Middle Aged Molecular Medicine Occult Blood Oncology Regular regular-article Sensitivity and Specificity Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Tumors |
title | Colorectal cancer after a negative Haemoccult II test and programme sensitivity after a first round of screening: The experience of the Department of Calvados (France) |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T14%3A32%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Colorectal%20cancer%20after%20a%20negative%20Haemoccult%20II%20test%20and%20programme%20sensitivity%20after%20a%20first%20round%20of%20screening:%20The%20experience%20of%20the%20Department%20of%20Calvados%20(France)&rft.jtitle=British%20Journal%20of%20Cancer&rft.au=Bouvier,%20V&rft.date=1999-09-01&rft.volume=81&rft.issue=2&rft.spage=305&rft.epage=309&rft.pages=305-309&rft.issn=0007-0920&rft.eissn=1476-5381&rft.coden=BJCAAI&rft_id=info:doi/10.1038/sj.bjc.6990692&rft_dat=%3Cproquest_pubme%3E70049004%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c477t-382242d9f006e917999f53ebe55ebf9278c30261b9567f524ab8e1b7d3657fe23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70049004&rft_id=info:pmid/10496357&rfr_iscdi=true |